Decibel Therapeutics, Inc.
DelistedCIK 1656536fmd_070X5B8HJP2SSB75BBG6BTZ1W8Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Jun 30, 2023, 14 periods
Latest annual · FY2022
Millions- Operating income
- (64)
- Net income
- (63)
- Free cash flow
- (57)
Latest quarter · Q2 FY2023
Millions- Operating income
- (19)
- Net income
- (18)
- Free cash flow
- (10)
Decibel Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Operating income | -$64 million | -$50.2 million | 10-K 2023-03-14 · proof | |
| Net income | -$63 million | -$51.8 million | 10-K 2023-03-14 · proof | |
| Cash from operating activities | -$56.9 million | -$43.2 million | 10-K 2023-03-14 · proof | |
| Free cash flow | -$57.4 million | -$43.9 million | 10-K 2023-03-14 · proof | |
| Total assets | $123.4 million | $184.5 million | -33.1% | 10-K 2023-03-14 · proof |
| Total liabilities | $41.6 million | $42.8 million | -2.8% | 10-K 2023-03-14 · proof |
| Cash and cash equivalents | $34.6 million | $36.5 million | -5.1% | 10-K 2023-03-14 · proof |
- What was Decibel Therapeutics, Inc.'s operating income in fiscal 2022?
- Decibel Therapeutics, Inc. reported operating income of -$64 million for fiscal 2022 (the year ended Dec 31, 2022), against -$50.2 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2023. SEC
- What was Decibel Therapeutics, Inc.'s net income in fiscal 2022?
- Decibel Therapeutics, Inc. reported net income of -$63 million for fiscal 2022 (the year ended Dec 31, 2022), against -$51.8 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2023. SEC
- What was Decibel Therapeutics, Inc.'s cash from operating activities in fiscal 2022?
- Decibel Therapeutics, Inc. reported cash from operating activities of -$56.9 million for fiscal 2022 (the year ended Dec 31, 2022), against -$43.2 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2023. SEC
- What was Decibel Therapeutics, Inc.'s free cash flow in fiscal 2022?
- Decibel Therapeutics, Inc. reported free cash flow of -$57.4 million for fiscal 2022 (the year ended Dec 31, 2022), against -$43.9 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2023. SEC
- What are Decibel Therapeutics, Inc.'s total assets?
- As of Dec 31, 2022, Decibel Therapeutics, Inc. reported total assets of $123.4 million, against $184.5 million a year earlier (-33.1%). Source: the 10-K filed with the SEC on Mar 14, 2023. SEC
- What are Decibel Therapeutics, Inc.'s total liabilities?
- As of Dec 31, 2022, Decibel Therapeutics, Inc. reported total liabilities of $41.6 million, against $42.8 million a year earlier (-2.8%). Source: the 10-K filed with the SEC on Mar 14, 2023. SEC
- What are Decibel Therapeutics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Decibel Therapeutics, Inc. reported cash and cash equivalents of $34.6 million, against $36.5 million a year earlier (-5.1%). Source: the 10-K filed with the SEC on Mar 14, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1656536&period_type=annual&limit=5"Information only, not investment advice.